Evidence map›Paper›PMID 38254790›Full record

ReviewCancers2024

Advances in the Use of Deep Learning for the Analysis of Magnetic Resonance Image in Neuro-Oncology.

Carla Pitarch, Gulnur Ungan, Margarida Julià-Sapé, Alfredo Vellido

Abstract readReview
In one paragraph

Review in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. [Application of hybrid attention guided dual-path residual learning in magnetic resonance imaging diagnosis].Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2026
    Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Carla PitarchDepartment of Computer Science, Universitat Politècnica de Catalunya (UPC BarcelonaTech) and Intelligent Data Science and Artificial Intelligence (IDEAI-UPC) Research Center, 08034 Barcelona, Spain.ORCID 0000-0002-6015-244X
Gulnur UnganDepartament de Bioquímica i Biologia Molecular and Institut de Biotecnologia i Biomedicina (IBB), Universitat Autònoma de Barcelona (UAB), 08193 Barcelona, Spain.ORCID 0000-0002-5436-4665
Margarida Julià-SapéDepartament de Bioquímica i Biologia Molecular and Institut de Biotecnologia i Biomedicina (IBB), Universitat Autònoma de Barcelona (UAB), 08193 Barcelona, Spain.ORCID 0000-0002-3316-9027
Alfredo VellidoDepartment of Computer Science, Universitat Politècnica de Catalunya (UPC BarcelonaTech) and Intelligent Data Science and Artificial Intelligence (IDEAI-UPC) Research Center, 08034 Barcelona, Spain.ORCID 0000-0002-9843-1911

Funding

Agencia Española de Investigación PID2019-104551RB-I00H2020-EU.1.3. - EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions H2020-MSCA-ITN-2018-813120Proyectos de investigación en salud 2020 PI20/00064XartecSalut 2021-XARDI-00021
6 · The paper itself

Abstract

Machine Learning is entering a phase of maturity, but its medical applications still lag behind in terms of practical use. The field of oncological radiology (and neuro-oncology in particular) is at the forefront of these developments, now boosted by the success of Deep-Learning methods for the analysis of medical images. This paper reviews in detail some of the most recent advances in the use of Deep Learning in this field, from the broader topic of the development of Machine-Learning-based analytical pipelines to specific instantiations of the use of Deep Learning in neuro-oncology; the latter including its use in the groundbreaking field of ultra-low field magnetic resonance imaging.

Indexed as

data analysis pipelinedeep learningmachine learningneuro-oncologyradiologyultra-low field magnetic resonance imaging

Identifiers

PMID38254790
PMCPMC10814384

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.